Syed Hasan to Rheumatic Diseases
This is a "connection" page, showing publications Syed Hasan has written about Rheumatic Diseases.
Connection Strength
0.276
-
Use of rituximab and the risk of adverse clinical outcomes in COVID-19 patients with systemic rheumatic disease. Rheumatol Int. 2020 12; 40(12):2117-2118.
Score: 0.276
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.